A growing generics sector, combined with the introduction of compulsory licensing, will lead to a dramatic revenue drop in China's HIV therapeutics market in the near future, predicts research and consulting firm The authors.
http://ift.tt/1pxWvgX
http://ift.tt/1pxWvgX
No comments:
Post a Comment